Books on the topic 'Nonsteroidal anti-inflammatory agents'

J, Lowe N., and Hensby C. N, eds. Nonsteroidal anti-inflammatory drugs. Basel: Karger, 1989.

G, Lombardino J., ed. Nonsteroidal antiinflammatory drugs. New York: Wiley, 1985.

1945-, Lewis Alan, and Furst Daniel E. 1942-, eds. Nonsteroidal anti-inflammatory drugs: Mechanisms and clinical uses. 2nd ed. New York: M. Dekker, 1994.

1945-, Lewis Alan, and Furst Daniel E. 1942-, eds. Nonsteroidal anti-inflammatory drugs: Mechanisms and clinical use. New York: Dekker, 1987.

P, Famaey J., and Paulus H. E, eds. Therapeutic applications of NSAIDs: Subpopulations and new formulations. New York: M. Dekker, 1992.

Peter, Brooks, and World Conference on Variability in Response to Anti-Rheumatic Drugs (3rd : 1992 : Singapore), eds. Variability in response to anti-rheumatic drugs. Basel: Birkhäuser Verlag, 1993.

Robinson, Dwight R., and Fred E. Silverstein. Nonsteroidal anti-inflammatory drug-induced gastrointestinal damage: Current insights into patient management. Newton, MA: Cahners Pub. Co., 1988.

D, Solomon Leon, and American Academy of Ophthalmology. Meeting, eds. NSAIDs and combination therapies in ophthalmic practice. Montreal: Medicöpea, 1997.

Peter, Brooks, Day Richard, and Symposium on Non-steroidal Anti-inflammatory Drugs, Basis for Variability in response (1985 : Leura, N.S.W.), eds. Non-steroidal anti-inflammatory drugs, basis for variability in response: 16-18 May, 1985, at Leura, New South Wales, Australia. Basel: Birkhäuser, 1985.

Kari, Frank W. NTP technical report on the toxicology and carcinogenesis studies of phenylbutazone (CAS no. 50-33-9) in F344/N rats and B6C3F1 mice (gavage studies). Research Triangle Park, NC: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1990.

Reform, United States Congress House Committee on Government. Risk and responsibility: The roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005. Washington: U.S. G.P.O., 2005.

International Symposium on the Use of Non-steroidal Anti-inflammatory Drugs in Domesticated Animals (1992 Nuremberg, Germany). International Symposium on the Use of Non-steroidal Anti-inflammatory Drugs in Domesticated Animals: Proceedings of an international symposium held as part of the annual scientific program of the Bundesverband Praktischer Tierärzte (BPT), September 12, 1992, Nürnberg, Germany. [S.l.]: Schering-Plough Animal Health, 1992.

Peter, Brooks, ed. Basis for variability of response to anti-rheumatic drugs: Proceedings of a satellite meeting of the Xth International Congress of Pharmacology, held in Sydney, Australia, August 20-22, 1987. Basel: Birkhäuser Verlag, 1988.

Vane, John R. Improved non-steroid anti-flammatory drugs COX-2 enzyme inhibitors: Proceedings of a conference held on October 10-11, 1995, at Regent's College, London. Dordrecht: Kluwer Academic Publishers, 1996.

1941-, Rainsford K. D., and Powanda M. C, eds. Safety and efficacy of non-prescription (OTC) analgesics and NSAIDs: Proceedings of the international conference held at the South San Francisco Conference Center, San Francisco, CA, USA on Monday 17th March 1997. Dordrecht: Kluwer, 1998.

Raud, Johan. Intravital microscopic studies on acute mast cell-dependent inflammation. Stockholm: Published for the Scandinavian Physiological Society by Blackwell Scientific Publication, 1989.

G, Bazán Nicolás, Botting Jack H, and Vane John R, eds. New targets in inflammation: Inhibitors of COX-2 or adhesion molecules : proceedings of a conference held on April 15-16, 1996, in New Orleans, USA, supported by an educational grant from Boehringer Ingelheim. Dordrecht: Kluwer Academic Publishers, 1996.

William Harvey Conference (1995 London, England). Improved non-steroid anti-inflammatory drugs: COX-2 enzyme inhibitors : proceedings of a conference held on October 10-11, 1995, at Regent's College, London. Dordrecht: Kluwer Academic, 1996.

N, Cohn Jay, and Abrams William B, eds. Cardiovascular drugs. Mount Kisco, N.Y: Futura Pub. Co., 1985.

W, Houde Raymond, Ley Timothy J, and Hollister Leo E. 1920-, eds. Analgesics and NSAID. Mount Kisco, N.Y: Futura Pub. Co., 1985.

Maetzel, Andreas. Economic assessment: Celecoxib and rofecoxib for patients with osteoarthritis or rheumatoid arthritis. Ottawa, Ont: Canadian Coordinating Office for Health Technology Assessment, 2002.

Parker, Philip M., and James N. Parker. Nabumetone: A medical dictionary, bibliography, and annotated research guide to Internet references. San Diego, CA: ICON Health Publications, 2004.

E, Harris Randall, ed. Inflammation in the pathogenesis of chronic diseases: The COX-2 controversy. New York: Springer, 2007.

Maetzel, Andreas. The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis. Ottawa, Ont: Canadian Coordinating Office for Health Technology Assessment, 2002.

Flores, Diane. Nonsteroidal Anti-Inflammatory Drugs: Common Uses, Risks and Effectiveness. Nova Science Publishers, Incorporated, 2017.

Čalija, Bojan. Microsized and Nanosized Carriers for Nonsteroidal Anti-Inflammatory Drugs: Formulation Challenges and Potential Benefits. Elsevier Science & Technology Books, 2017.

Calija, Bojan. Microsized and Nanosized Carriers for Nonsteroidal Anti-Inflammatory Drugs: Formulation Challenges and Potential Benefits. Elsevier Science & Technology Books, 2017.

Safety, efficacy and mechanisms: A guide to NSAID use in general practice. London: Royal Society of Medicine Press, 1998.

Hobbs, F. D. R. Safety, Efficacy and Mechanisms: A Guide to NSAID Use in General Practice (Round Table Series (RTS)). Royal Society of Medicine Press Ltd, 1999.

Lewis, Alan J. Nonsteroidal Anti-Inflammatory Drugs: Mechanisms and Clinical Use (Clinical Pharmacology Series, No 10). Marcel Dekker Inc, 1987.

Vane, Sir John, ed. Clinical Significance And Potential Of Selective Cox-2 Inhibitors. WILLIAM HARVEY PRESS, 1998.

Selective COX-2 inhibitors: Pharmacology, clinical effects, and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France. Dordrecht: Kluwer Academic, 1998.

R, Vane John, Botting Jack H, and William Harvey Research Conference (1997 : Cannes, France), eds. Selective COX-2 inhibitors: Pharmacology, clinical effects and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France. Dordrecht: Kluwer Academic, 1998.

Sir John R. Vane (Editor) and Jack H. Botting (Editor), eds. Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential. Springer, 1998.

Botting, Jack H., and Sir John R. Vane. Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential. Springer, 2012.

Holt, Kris Edward. Bioequivalence studies of ketoprofen: Product formulation, pharmacokinetics, deconvolution, and in vitro - in vivo correlations. 1997.

COX-2 Inhibitor Research. Nova Science Publishers, 2006.

Howardell, Maynard J. Cox-2 Inhibitor Research. Nova Science Publishers, Incorporated, 2006.

Risk and Responsibility: The Roles of FDA and Pharmaceutical Companies in Ensuring the Safety of Approved Drugs, Like Vioxx: Hearing Before the. Not Avail, 2005.

Choosing NSAID therapy: An international reappraisal. ADIS Press, 1985.

Howardell, Maynard J. Trends in Cox-2 Inhibitor Research. Nova Science Publishers, 2006.

Bazan, N., Jack H. Botting, and Sir John R. Vane. New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules Proceedings of a Conference Held on April 15-16, 1996, in New Orleans, USA, Supported by an Educational Grant from Boehringer Ingelheim. Springer London, Limited, 2012.

T, Borda Ivan, and Koff Raymond S. 1939-, eds. NSAIDs: A profile of adverse effects. Philadelphia, Pa: Hanley & Belfus, 1992.

Borda, Ivan T., and Raymond S., M.D. Koff. Nsaids: A Profile of Adverse Effects. Lippincott Williams & Wilkins, 1992.

Borda, Ivan T. NSAIDs. Hanley & Belfus, 1992.

IARC Working Group on the Evaluation of Cancer Preventive Agents. IARC Handbooks of Cancer Prevention, Volume 1: Non-Steroidal Anti-Inflammatory Drugs. Oxford University Press, USA, 1997.

(Editor), K. D. Rainsford, and M. C. Powanda (Editor), eds. Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs. Springer, 1997.

H, Stewart J., ed. Analgesic and NSAID-induced kidney disease. Oxford: Oxford University Press, 1993.

Day and Brooks. The Proceedings of a Symposium on Non-steroidal Antiinflammatory Drugs - Basis for Variability in Response (Agents and Actions Supplements). Birkhauser, 1985.

Peter, Brooks, Day Richard, and International Congress of Rheumatology, (16th : 1985 : Leura, N.S.W.), eds. Non-steroidal antiinflammatory drugs: Basis for variability in response. Basel: Birkhäuser, 1985.